Kalvista Pharmaceuticals Inc (KALV) PT Lowered to $30 at Stifel

October 7, 2019 7:40 AM EDT
Get Alerts KALV Hot Sheet
Price: $27.00 --0%

Rating Summary:
    7 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Paul Matteis lowered the price target on Kalvista Pharmaceuticals Inc (NASDAQ: KALV) to $30.00 (from $33.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change